RU2017108908A - Замещенное в положении c-4" макролидное производное - Google Patents

Замещенное в положении c-4" макролидное производное Download PDF

Info

Publication number
RU2017108908A
RU2017108908A RU2017108908A RU2017108908A RU2017108908A RU 2017108908 A RU2017108908 A RU 2017108908A RU 2017108908 A RU2017108908 A RU 2017108908A RU 2017108908 A RU2017108908 A RU 2017108908A RU 2017108908 A RU2017108908 A RU 2017108908A
Authority
RU
Russia
Prior art keywords
substituted
macrolide derivative
compound
solvate
hydrate
Prior art date
Application number
RU2017108908A
Other languages
English (en)
Inventor
Томохиро СУГИМОТО
Масато ХАЯСИ
Таканори КАВАГУТИ
Original Assignee
Тайсо Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тайсо Фармасьютикал Ко., Лтд. filed Critical Тайсо Фармасьютикал Ко., Лтд.
Publication of RU2017108908A publication Critical patent/RU2017108908A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Claims (5)

1. Соединение, представленное формулой [1]:
Figure 00000001
или его фармацевтически приемлемая соль, или его гидрат или сольват.
2. Фармацевтическая композиция, содержащая соединение, выбранное из группы, состоящей из соединения, его фармацевтически приемлемой соли и его гидрата и сольвата по п. 1.
3. Антибактериальное средство, содержащее соединение, выбранное из группы, состоящей из соединения, его фармацевтически приемлемой соли и его гидрата и сольвата по п. 1.
RU2017108908A 2014-08-18 2015-08-17 Замещенное в положении c-4" макролидное производное RU2017108908A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014165848 2014-08-18
JP2014-165848 2014-08-18
PCT/JP2015/072993 WO2016027755A1 (ja) 2014-08-18 2015-08-17 Ｃ－４"位置換マクロライド化合物

Publications (1)

Publication Number Publication Date
RU2017108908A true RU2017108908A (ru) 2018-09-21

Family

ID=55350700

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017108908A RU2017108908A (ru) 2014-08-18 2015-08-17 Замещенное в положении c-4" макролидное производное

Country Status (19)

Country Link
US (1) US20170267708A1 (ru)
EP (1) EP3192798A4 (ru)
JP (1) JP5874871B1 (ru)
KR (1) KR20170036106A (ru)
CN (1) CN106573953A (ru)
AR (1) AR102810A1 (ru)
AU (1) AU2015304439A1 (ru)
BR (1) BR112017000606A2 (ru)
CA (1) CA2957628A1 (ru)
CL (1) CL2017000395A1 (ru)
CO (1) CO2017002440A2 (ru)
IL (1) IL250559A0 (ru)
MX (1) MX2017002223A (ru)
PE (1) PE20170467A1 (ru)
PH (1) PH12017500223A1 (ru)
RU (1) RU2017108908A (ru)
SG (1) SG11201701146TA (ru)
TW (1) TW201625656A (ru)
WO (1) WO2016027755A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017142002A1 (ja) * 2016-02-17 2017-08-24 大正製薬株式会社 Ｃ－４"位置換マクロライド化合物フリー体及び塩の結晶形並びにそれらの製造方法
CN114231430B (zh) * 2021-06-11 2024-02-09 常州大学 一种红霉素降解菌iurm f57及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54967A (en) 1977-06-06 1979-01-06 Mitsubishi Electric Corp Output circuit
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
ATE296832T1 (de) 1996-09-04 2005-06-15 Abbott Lab 6-o-substituierte ketoliden mit antibakteriellen wirkung
HN1998000074A (es) 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
UY26964A1 (es) 2000-10-16 2002-06-20 Abbott Lab Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 Ｃ−４”位置換マクロライド誘導体を含有する医薬
JP2014058507A (ja) * 2012-08-20 2014-04-03 Taisho Pharmaceutical Co Ltd １１位アミノ置換マクロライド誘導体
JP2014058508A (ja) * 2012-08-20 2014-04-03 Taisho Pharmaceutical Co Ltd ９位オキシム置換マクロライド誘導体

Also Published As

Publication number Publication date
EP3192798A4 (en) 2018-01-03
JPWO2016027755A1 (ja) 2017-04-27
MX2017002223A (es) 2017-05-09
WO2016027755A1 (ja) 2016-02-25
CL2017000395A1 (es) 2018-01-05
US20170267708A1 (en) 2017-09-21
IL250559A0 (en) 2017-03-30
PE20170467A1 (es) 2017-04-26
BR112017000606A2 (pt) 2017-11-07
JP5874871B1 (ja) 2016-03-02
AU2015304439A1 (en) 2017-03-16
KR20170036106A (ko) 2017-03-31
PH12017500223A1 (en) 2017-07-10
SG11201701146TA (en) 2017-03-30
TW201625656A (zh) 2016-07-16
CN106573953A (zh) 2017-04-19
EP3192798A1 (en) 2017-07-19
CA2957628A1 (en) 2016-02-25
AR102810A1 (es) 2017-03-29
CO2017002440A2 (es) 2017-04-28

Similar Documents

Publication Publication Date Title
RU2021133039A (ru) Молекулы, применимые в качестве пестицидов, и связанные с ними промежуточные продукты, композиции и способы
JP2014221779A5 (ru)
CN106536480A8 (zh) 吡咯烷‑2,5‑二酮衍生物、药物组合物及用作ido1抑制剂的方法
HRP20210529T1 (hr) Inhibitori za mk2 i njihove uporabe
WO2016064082A3 (ko) 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도
EP4006016A3 (en) Probes for imaging huntingtin protein
WO2014152389A8 (en) Imaging agent for detection of diseased cells
JP2011105738A5 (ru)
CL2016001918A1 (es) Heteroaril amidas como inhibidores de agregación de proteína
MY182884A (en) Pyrazole-amide compound and medicinal uses therefor
JP2013532130A5 (ru)
MX2018009459A (es) Derivado de sulfonamida y composicion farmaceutica que contiene el mismo.
WO2015000431A9 (zh) 替唑尼特氨基甲酸酯及其在药学中的应用
BR112015019587A2 (pt) combinações compreendendo compostos maba e corticosteroides
MX2017007573A (es) Composicion acuosa novedosa.
RU2018101431A (ru) Ингибиторы индоламин-2,3-диоксигеназы
CA2922375C (en) Alpha-tea salt forms: compositions and uses for treating disease
EA201492029A1 (ru) N-этил-4-гидроксил-1-метил-5-(метил(2,3,4,5,6-пентагидроксигексил)амино)-2-оксо-n-фенил-1,2-дигидрохинолин-3-карбоксамид
JP2017531686A5 (ru)
AR090073A1 (es) N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos
EA201692270A1 (ru) Производные нафтиридиндиона
WO2015002755A3 (en) Compounds for the treatment of malaria
RU2017108908A (ru) Замещенное в положении c-4" макролидное производное
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof